In the present study, we demonstrated that estrogen activates the Akt pathway not only stimulating proliferation but also promoting EMT in ER-negative, BRCA1-deficient tumor cells, which further enhances tumor progression. The gene discussed is BRCA1; the disease is neoplasm.